Alliqua BioMedical, Inc. Announces Definitive Asset Purchase Agreement with Celularity, Inc.
Jan 05, 2018 21:30 pm UTC| Business
YARDLEY, Pa., Jan. 05, 2018 -- Alliqua BioMedical, Inc. (NASDAQ:ALQA) (“Alliqua or the “Company”), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced a definitive...
Drake’s new Toronto restaurant Pick 6ix will feature an OpenAire custom patio design
Jan 05, 2018 21:30 pm UTC| Business
OAKVILLE, Ontario, Jan. 05, 2018 -- Social media in Toronto was buzzing in August 2017 after construction signage appeared on a property at the corner of Yonge and Wellington Street with the distinctive logo of Drake’s...
Perry Ellis International Signs Licensing Deal For An Original Penguin By Munsingwear®
Jan 05, 2018 21:30 pm UTC| Business
MIAMI, Jan. 05, 2018 -- Perry Ellis International, Inc. (Nasdaq:PERY), announced today that it has entered into a licensing agreement with Cia. Mexicana de Trajes, S.A. de C.V. granting rights to design and distribute...
ReWalk Robotics Ltd. Appoints Ori Gon as Chief Financial Officer
Jan 05, 2018 21:30 pm UTC| Business
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 05, 2018 -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq:RWLK) today announced the Company has appointed its Corporate Controller, Ori Gon as Chief Financial...
Kite Realty Group Trust to Report Fourth Quarter 2017 Financial Results on February 1, 2018
Jan 05, 2018 21:20 pm UTC| Business
INDIANAPOLIS, Jan. 05, 2018 -- Kite Realty Group Trust (NYSE:KRG) announced today that it will release financial results for the quarter ended December 31, 2017, after the market closes on Thursday, February 1. The...
A. Schulman Declares Regular and Convertible Special Stock Cash Dividends
Jan 05, 2018 21:15 pm UTC| Business
AKRON, Ohio, Jan. 05, 2018 -- A. Schulman, Inc. (Nasdaq:SHLM) announces a regular quarterly cash dividend of $0.205 per common share, payable February 1, 2018, to shareholders of record on January 15, 2018. ...
Jan 05, 2018 21:15 pm UTC| Business
CAMBRIDGE, Mass., Jan. 05, 2018 -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious cardiometabolic...